CSAI vs GSK · rev $5.1M vs P/E 13, $103.31B cap
Cloudastructure, Inc. Class A Common Stock (CSAI) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Cloudastructure, Inc. Class A Common Stock (CSAI) is a software - infrastructure company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported CSAI revenue for 2025-12-31 was $5.1M. Net income was -$8.5M. Revenue was up 271.4% from 2024-12-31 to 2025-12-31. CSAI currently screens at market cap $278.0M.
GSK does not have a complete income-statement cache yet.
CSAI currently screens at market cap $278.0M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the CSAI and GSK stock pages for the full models.
Not investment advice.